CS Investment Funds 2 - UBS (Lux) Digital Health Equity Fund IB USDRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 82.1 | -18.5 | -27.8 | 3.1 | -3.7 | |
+/-Cat | 64.6 | -27.9 | -23.1 | 6.2 | -8.2 | |
+/-B’mrk | - | -36.7 | -33.6 | 5.7 | -12.0 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 08/10/2024 | USD 717.83 | |
Day Change | -0.63% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | LU1683285750 | |
Fund Size (Mil) 07/10/2024 | USD 1064.48 | |
Share Class Size (Mil) 07/10/2024 | USD 87.26 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 01/02/2024 | 1.16% |
Investment Objective: CS Investment Funds 2 - UBS (Lux) Digital Health Equity Fund IB USD |
The objective of the Subfund is to achieve the highest possible return in US dollars (Reference Currency), while taking due account of the principle of risk diversification, the security of the capital invested, and the liquidity of the assets. This Subfund aims to outperform the return of the MSCI World ESG Leaders (NR) benchmark. The Subfund is actively managed. The benchmark is used as a reference point for portfolio construction and as a basis for setting risk constraints, and/or for Performance Fee measurement purposes. The majority of the Subfund’s equity securities will not necessarily be components of or have weightings derived from the benchmark. The Investment Manager will use its discretion to significantly deviate the weighting of certain components of the benchmark and to significantly invest in companies or sectors not included in the benchmark in order to take advantage of specific investment opportunities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Thomas Amrein 14/12/2017 | ||
Inception Date 14/12/2017 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World ESG Leaders NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for CS Investment Funds 2 - UBS (Lux) Digital Health Equity Fund IB USD | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
Zai Lab Ltd Ordinary Shares | Healthcare | 4.35 |
Veeva Systems Inc Class A | Healthcare | 4.04 |
Zealand Pharma AS | Healthcare | 4.00 |
TransMedics Group Inc | Healthcare | 3.94 |
Redcare Pharmacy NV | Healthcare | 3.87 |
Increase Decrease New since last portfolio | ||
CS Investment Funds 2 - UBS (Lux) Digital Health Equity Fund IB USD |